Johnson & Johnson
JNJ
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGXā¦ read more
Healthcare
Drug Manufacturers - General
81 years
USD
85
/100
Price
per share adjusted in USD$234.47
Price+0.59%
$1.37
1Y
Price
Market Cap
$564.907b
Large
Price/Earnings
21.3x
20.1x
3y Avg21.5x
5y AvgFinancial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+18.1%
EBITDA Margin+20.8%
Net Profit Margin+34.1%
Free Cash Flow Margin+18.1%
EBITDA Margin+20.8%
Net Profit Margin+34.1%
Free Cash Flow MarginRevenue
$94.193b
+6.1%
1y CAGR+5.6%
3y CAGR+4.6%
5y CAGREarnings
$26.804b
+90.6%
1y CAGR+42.2%
3y CAGR+28.1%
5y CAGREPS
$11.03
+90.9%
1y CAGR+45.6%
3y CAGR+30.8%
5y CAGRBook Value
$71.490b
$180.104b
Assets$108.614b
Liabilities$36.634b
DebtDebt to Assets
20.3%
1.2x
Debt to EBITDAFree Cash Flow
$19.842b
+4.5%
1y CAGR-0.8%
3y CAGR-1.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company